Identifying Proteins Linked to Gallbladder Cancer Progression
Author Information
Author(s): Rawal Neetu, Hariprasad Gururao, Bandyopadhyay Sabyasachi, Dash Nihar Ranjan, Kumar Sunil, Das Prasenjit, Dey Sharmistha, Khan Maroof Ahmad, Ranjan Amar, Chopra Anita, Saluja Sundeep, Hussain Showket, Rath GK, Kaur Tanvir, Tanwar Pranay
Primary Institution: All India Institute of Medical Sciences, New Delhi, India
Hypothesis
This study aims to identify and validate proteins associated with the progression of gallbladder inflammatory lesions to invasive cancer.
Conclusion
The study identified five potential protein biomarkers that may help in diagnosing and predicting the progression of gallbladder cancer.
Supporting Evidence
- Out of 5714 proteins analyzed, 621 were differentially expressed.
- Three proteins (S100P, PIGR, C1QBP) were significantly upregulated, while two proteins (TAGLN, CNN1) were downregulated.
- Significant correlations were observed between protein concentrations and clinicopathological variables.
Takeaway
Researchers found specific proteins that could help doctors tell if someone with gallbladder inflammation might develop cancer.
Methodology
The study used label-free liquid chromatography-assisted tandem mass spectrometry (LC-MS/MS) and enzyme-linked immunosorbent assay (ELISA) to analyze protein expression in gallbladder tissue samples.
Potential Biases
Potential biases may arise from the selection of samples and the methods used for protein analysis.
Limitations
The study had a small sample size and focused only on specific proteins, which may limit the generalizability of the findings.
Participant Demographics
The study included 80 patients, with 40 diagnosed with gallbladder cancer and 40 with inflammatory lesions, with a median age of 52 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website